bethanechol has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of bethanechol in the treatment of dry mouth were assessed in patients with xerostomia after radiation therapy to the head and neck." | 9.07 | A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. ( Burchell, JL; Emerton, S; Epstein, JB; Le, ND; Silverman, S, 1994) |
| "The effects of bethanechol in the treatment of dry mouth were assessed in patients with xerostomia after radiation therapy to the head and neck." | 5.07 | A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. ( Burchell, JL; Emerton, S; Epstein, JB; Le, ND; Silverman, S, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epstein, JB | 1 |
| Burchell, JL | 1 |
| Emerton, S | 1 |
| Le, ND | 1 |
| Silverman, S | 1 |
1 trial available for bethanechol and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study.
Topics: Bethanechol; Bethanechol Compounds; Carcinoma, Squamous Cell; Cranial Irradiation; Female; Head and | 1994 |